# Trade Mark Journal No.2025/040 3 October 2025

## WO0000001876039 (5)

Office of origin: United States of America

Date of International Registration:18 August 2025
Date of designation in the UK: 18 August 2025

International priority date claimed: 24 February 2025 (United States of America) (99053194)

Class 5
  Pharmaceutical preparations for the treatment and prevention of lymphopenia; pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections; pharmaceutical preparations for use in stimulating lymphocyte production; pharmaceutical preparations for maintenance of lymphocyte counts.

ImmunityBio, Inc.

Representative: Alicia M. Passerin Leech Tishman Fuscaldo & Lampl, 525 William Penn Place, 28th Floor, Pittsburgh PA 15219, UNITED STATES OF AMERICA